NEWS CENTER

Our core products have once again earned prestigious recognition! Two products from Kexuan Pharmaceutical’s subsidiary have been proudly listed among the "Family Essential Medicines" brands!

Publish Time:

2025-11-18

On November 18, the award ceremony for the "2024-2025 Family Essential Medicines List Brand" event—hosted by Family Doctor Online—concluded successfully during the Autumn Nanjing exhibition of the 91st National Pharmaceutical Fair. Recognized as an authoritative benchmark in the field of family health and medicine, the event is hailed within the industry as the "leading indicator for essential healthcare products families should consider." All brands selected for the list underwent rigorous multi-stage screening processes, including eligibility checks, market research, public voting, and expert evaluations, ensuring both the quality and reputation of the featured products while also aiming to provide consumers with a scientifically sound guide for building their household medicine kits.

On November 18, the award ceremony for the "2024-2025 Family Essential Medicines List Brand" event—hosted by Family Doctor Online—concluded successfully during the autumn Nanjing exhibition of the 91st National Pharmaceutical Fair. As an authoritative benchmark in the field of family health and medication, this event is hailed within the industry as the "leading indicator for essential household health products." All brands selected for the list underwent rigorous multi-stage screening processes, including eligibility checks, market research, public voting, and expert evaluations, ensuring both the quality and reputation of the featured products. Ultimately, the initiative aims to provide consumers with a reliable guide for smart medicine preparation. At the same time, the event has also created a platform for pharmaceutical companies to focus on addressing public health needs and driving high-quality development, firmly establishing itself as a vital bridge connecting the strength of the pharmaceutical industry with the evolving demands of family health.

In this selection, Linuo Pharmaceutical has impressively clinched three prestigious awards, thanks to its deep industry expertise, exceptional product quality, and widespread market recognition: — The company was honored with the "Consumer-Favorite Enterprise Award," highlighting its robust brand strength and stellar market reputation; — Its flagship product, Fures ® Amlodipine Paste, was named among the top brands in the "Oral & Throat Medicines" category, while Xinsu ® Isosorbide Mononitrate Spray earned a spot as a leading brand in the "Cardiovascular & Cerebrovascular Medicines" category! These remarkable accolades not only reflect the high regard from both the industry and consumers but also serve as powerful testament to the company's unwavering commitment to excellence and its steadfast dedication to delivering premium-quality pharmaceutical solutions.

Lilun Pharmaceutical Wins the "Consumer-Favorite Enterprise Award"

Forrest ® Aminecaine Ointment Named as a Featured Brand in the "Oral and Throat Medicines" Category

Xinshu® Isosorbide Dinitrate Spray Named Among Top Brands in "Cardiovascular and Cerebrovascular Medicines"

Strength forges glory, and craftsmanship safeguards health.

Founded in 2002, Linuo Pharmaceutical is a wholly owned subsidiary of the publicly listed company Keyuan Pharmaceutical (stock code: 301281.SZ), a high-tech enterprise, one of China's fastest-growing pharmaceutical companies, and a specialized, refined, and innovative enterprise in Jinan City.

In recent years, the company has accelerated its digital and intelligent transformation, establishing three major smart manufacturing production bases in Shanghe, Yinan, and Jinan. Leveraging AI-driven innovation, capital-led initiatives, and integrated advantages across raw materials, excipients, and finished dosage forms, the company has built a diversified product portfolio encompassing injectables, oral solutions, drops, topical preparations, pastes, sprays, and more. This strategic approach has enabled the company to forge competitive edges in cost control, quality, and production capacity.

The attainment of these three prestigious honors reflects both the industry and market's high recognition of Linuo Pharmaceutical's steadfast commitment over the past 20+ years to the company’s core philosophy: "Caring for Life and Health, Protecting a Better Life." It also serves as a comprehensive affirmation of the company’s robust R&D capabilities, rigorous quality control in manufacturing, and outstanding market services. Moving forward, Linuo Pharmaceutical will continue to drive product upgrades and innovative research and development, delivering even higher-quality pharmaceutical products and services that align with the "Healthy China" initiative. We remain committed to earning the trust of consumers and meeting the industry’s expectations, steadily advancing on the path to safeguarding the health of people across the nation!

Public Information on the Environmental Impact Assessment for Shandong Keyuan Pharmaceutical Co., Ltd.'s High-Efficiency, Continuous-Flow Digital Intelligent Factory Project for Isosorbide Mononitrate

Keyuan Pharmaceutical holds a marketing special meeting titled "Sprint for the Fourth Quarter," comprehensively outlining the closing-phase strategy.